Quantum-Si Inc
Close on Oct 19, 2026
- Market cap
- $237.40M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Next report expected Nov 4, 2026, after market close (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 13, 2026 | After market close | $344.00K | – | – |
| Q1 FY2026 Ended Mar 31, 2026 | May 7, 2026 | After market close | – | – | – |
| Q4 FY2025 Ended Dec 31, 2025 | Mar 3, 2026 | After market close | $451.00K | – | – |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 5, 2025 | After market close | $552.00K | $-0.17 | – |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 5, 2025 | After market close | – | – | – |
| Q1 FY2025 Ended Mar 31, 2025 | May 15, 2025 | After market close | $842.00K | – | – |
| Q4 FY2024 Ended Dec 31, 2024 | Mar 3, 2025 | After market close | $1.20M | – | – |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 12, 2024 | Before market open | – | – | – |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 7, 2024 | After market close | – | – | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 9, 2024 | After market close | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Feb 29, 2024 | After market close | – | – | – |
Company guidance
Outlook given with results on Mar 3, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Total cash usage | full year 2026 | $93.00M | New |
| Adjusted total operating expensesnon-GAAP | full year 2026 | $98.00M | New |
| Revenue | full year 2026 | $1.00M | New |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Quantum-Si filed with the SEC
EX-99.1 to Form 8-K
Other events · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Regulation FD disclosure · EX-99.1 to Form 8-K
1 ProteusTM The Future of Single-molecule Protein Sequencing World HUPO 2026 Exhibit 99.1
Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Regulation FD disclosure · EX-99.2 to Form 8-K
Quantum-Si Reports Second Quarter 2026 Financial Results and
Results of operations · EX-99.1 to Form 8-K
Use of Non-GAAP Financial Measures
Results of operations · EX-99.2 to Form 8-K
Quantum-Si Reports First Quarter 2026 Financial Results and Highlights Proteus TM Development Milestones
Results of operations · EX-99.1 to Form 8-K
Use of Non-GAAP Financial Measures
Results of operations · EX-99.2 to Form 8-K
Quantum-Si Reports Fourth Quarter and Full Year 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · EX-99.2 to Form 8-K
EX-99.1 to Form 8-K
Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Regulation FD disclosure · EX-99.1 to Form 8-K
Quantum-Si Reports Third Quarter 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · EX-99.2 to Form 8-K
Quantum-Si Reports Second Quarter 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · EX-99.2 to Form 8-K
Quantum-Si Incorporated Announces Pricing of $50 Million Registered Direct Offering of Common Stock
Material agreement · Agreement terminated · Other events · EX-99.1 to Form 8-K
Quantum-Si Reports First Quarter 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · EX-99.2 to Form 8-K
EX-99.1 to Form 8-K
Regulation FD disclosure · EX-99.1 to Form 8-K
Quantum-Si Reports Fourth Quarter and Full Year 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · EX-99.2 to Form 8-K
Investor & Analyst Day November 20, 2024
Regulation FD disclosure · EX-99.1 to Form 8-K
Quantum-Si Reports Third Quarter 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · EX-99.2 to Form 8-K
Forward Looking Statements This presentation includes "forward-looking
Regulation FD disclosure · EX-99.1 to Form 8-K
Quantum-Si Reports Second Quarter 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · EX-99.2 to Form 8-K
Forward Looking Statements This presentation includes "forward-looking
Regulation FD disclosure · EX-99.1 to Form 8-K
Quantum-Si Reports First Quarter 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
In addition to financial results calculated in accordance with U.S. generally accepted accounting principles (“GAAP”), information containing non-GAAP
Results of operations · EX-99.2 to Form 8-K
Forward Looking Statements This presentation includes "forward-looking
Regulation FD disclosure · EX-99.1 to Form 8-K
Quantum-Si Reports Fourth Quarter and Full Year 2023 Financial Results
Results of operations · EX-99.1 to Form 8-K
In addition to financial results calculated in accordance with U.S. generally accepted accounting principles (“GAAP”), information containing non-GAAP
Results of operations · EX-99.2 to Form 8-K
Quantum-Si Expands Proteome Coverage and Increases Sequencing Output with New Enhancements to Its Next-Generation Protein Sequencing™ Platform
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Quantum-Si Reports Third Quarter 2023 Financial Results
Results of operations · EX-99.1 to Form 8-K
In addition to financial results calculated in accordance with U.S. generally accepted accounting principles (“GAAP”), information containing
Results of operations · EX-99.2 to Form 8-K
Quantum-Si Reports Second Quarter 2023 Financial Results
Results of operations · EX-99.1 to Form 8-K
Quantum-Si Reports First Quarter 2023 Financial Results
Results of operations · EX-99.1 to Form 8-K